Maccura Biotechnology (300463.SZ) has obtained product registration certificates for two new products.

Maccura Biotechnology (300463.SZ) announced that the company has recently received a "Medical Device Registration Certificate" for in-vitro diagnostic reagents from the Sichuan Provincial Drug Administration. The products involved are "Urinary Transferrin Assay Kit (Latex Immunoassay Turbidimetry)" and "C-reactive Protein Assay Kit (Immunoturbidimetry)." The Urinary Transferrin Assay Kit (Latex Immunoassay Turbidimetry) is mainly used for the early auxiliary diagnosis of renal glomerular damage in conditions such as diabetic nephropathy and hypertension nephropathy. It is a new reagent product on the company's biochemical platform. The C-reactive Protein Assay Kit (Immunoturbidimetry) is mainly used for the auxiliary diagnosis of non-specific inflammation and is a new reagent product on the company's clinical platform. The acquisition of registration certificates for these new products further enriches the company's product portfolio. The registration of these products will help enhance the company's overall market competitiveness, positively impacting market expansion and the company's future operations.